The Coalition to Cure Calpain team is looking forward to working with the Critical Path Institute (C-Path), ML Bio Solutions, and our LGMD organization colleagues on this task force “dedicated to advancing therapeutic development for limb-girdle muscular dystrophies (LGMDs).”

Read the press release here.

C3 joins Task Force to advance therapeutic development for limb-girdle muscular dystrophies